Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $103M (100.0% shares, 0.0% debt)

Holdings (30)

RARE ULTRAGENYX PHARMACEUTICAL IN 8.4%

Value $8.583M Shares 185,261 Est. Cost $51.39 Unrealized -23.5%

WHWK AADI BIOSCIENCE INC 7.9%

Value $8.121M Shares 632,997 Est. Cost $13.07 Unrealized -0.1%

ACAD ACADIA PHARMACEUTICALS INC 7.4%

Value $7.558M Shares 474,741 Est. Cost $15.63 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 6.8%

Value $6.981M Shares 1,191,271 Est. Cost $6.56 Unrealized —

GLPG GALAPAGOS NV 6.0%

Value $6.216M Shares 140,054 Est. Cost $43.43 Unrealized —

— ALLAKOS INC 5.1%

Value $5.24M Shares 622,364 Est. Cost $6.21 Unrealized —

— SEAGEN INC 4.7%

Value $4.837M Shares 37,639 Est. Cost $136.83 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 4.5%

Value $4.631M Shares 962,694 Est. Cost $6.03 Unrealized -16.1%

— SAGE THERAPEUTICS INC 4.4%

Value $4.539M Shares 119,008 Est. Cost $39.08 Unrealized —

— AMARIN CORP PLC 4.4%

Value $4.514M Shares 3,730,859 Est. Cost $1.09 Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 3.9%

Value $4.044M Shares 326,428 Est. Cost $11.34 Unrealized +0.1%

SANA SANA BIOTECHNOLOGY INC 3.9%

Value $4.01M Shares 1,015,273 Est. Cost $6.58 Unrealized -25.6%

ALKS ALKERMES PLC 3.6%

Value $3.711M Shares 142,002 Est. Cost $26.01 Unrealized -8.0%

SYRS SYROS PHARMACEUTICALS INC 3.0%

Value $3.118M Shares 868,403 Est. Cost $8.12 Unrealized -46.6%

— KARYOPHARM THERAPEUTICS INC 3.0%

Value $3.049M Shares 896,618 Est. Cost $5.46 Unrealized —

— NEKTAR THERAPEUTICS 2.9%

Value $3.016M Shares 1,334,661 Est. Cost $2.56 Unrealized —

— SELECTA BIOSCIENCES INC 2.8%

Value $2.891M Shares 2,558,474 Est. Cost $1.20 Unrealized —

BHVN BIOHAVEN LTD 2.4%

Value $2.486M Shares 179,085 Est. Cost $14.12 Unrealized 0.0%

RCKT ROCKET PHARMACEUTICALS INC 2.4%

Value $2.45M Shares 125,176 Est. Cost $15.60 Unrealized +18.0%

— MIRATI THERAPEUTICS INC 2.1%

Value $2.153M Shares 47,520 Est. Cost $45.31 Unrealized —

RGEN REPLIGEN CORP 2.0%

Value $2.062M Shares 12,180 Est. Cost $210.87 Unrealized -14.0%

— ESSA PHARMA INC 2.0%

Value $2.045M Shares 811,555 Est. Cost $2.52 Unrealized —

— MEDAVAIL HOLDINGS INC 1.7%

Value $1.767M Shares 5,894,897 Est. Cost $8.23 Unrealized —

— PRAXIS PRECISION MEDICINES I 1.5%

Value $1.501M Shares 630,584 Est. Cost $2.38 Unrealized —

— MORPHOSYS AG 1.4%

Value $1.452M Shares 405,602 Est. Cost $3.92 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 0.8%

Value $791K Shares 699,664 Est. Cost $15.69 Unrealized -84.6%

— CURIS INC 0.4%

Value $455K Shares 827,397 Est. Cost $0.60 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 0.3%

Value $287K Shares 159,232 Est. Cost $10.83 Unrealized -82.2%

— SCIENCE 37 HOLDINGS INC 0.2%

Value $160K Shares 384,397 Est. Cost $2.01 Unrealized —

DNLI DENALI THERAPEUTICS INC 0.1%

Value $125K Shares 4,479 Est. Cost $29.75 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RARE	ULTRAGENYX PHARMACEUTICAL IN	185,261	$8.583M	8.4%	$51.39	-23.5%	COM	90400D108
WHWK	AADI BIOSCIENCE INC	632,997	$8.121M	7.9%	$13.07	-0.1%	COM	00032Q104
ACAD	ACADIA PHARMACEUTICALS INC	474,741	$7.558M	7.4%	$15.63	0.0%	COM	004225108
—	MERSANA THERAPEUTICS INC	1,191,271	$6.981M	6.8%	$6.56	—	COM	59045L106
GLPG	GALAPAGOS NV	140,054	$6.216M	6.0%	$43.43	—	SPON ADR	36315X101
—	ALLAKOS INC	622,364	$5.24M	5.1%	$6.21	—	COM	01671P100
—	SEAGEN INC	37,639	$4.837M	4.7%	$136.83	—	COM	81181C104
AVIR	ATEA PHARMACEUTICALS INC	962,694	$4.631M	4.5%	$6.03	-16.1%	COM	04683R106
—	SAGE THERAPEUTICS INC	119,008	$4.539M	4.4%	$39.08	—	COM	78667J108
—	AMARIN CORP PLC	3,730,859	$4.514M	4.4%	$1.09	—	SPONS ADR NEW	023111206
IRWD	IRONWOOD PHARMACEUTICALS INC	326,428	$4.044M	3.9%	$11.34	+0.1%	COM CL A	46333X108
SANA	SANA BIOTECHNOLOGY INC	1,015,273	$4.01M	3.9%	$6.58	-25.6%	COM	799566104
ALKS	ALKERMES PLC	142,002	$3.711M	3.6%	$26.01	-8.0%	SHS	G01767105
SYRS	SYROS PHARMACEUTICALS INC	868,403	$3.118M	3.0%	$8.12	-46.6%	COM NEW	87184Q206
—	KARYOPHARM THERAPEUTICS INC	896,618	$3.049M	3.0%	$5.46	—	COM	48576U106
—	NEKTAR THERAPEUTICS	1,334,661	$3.016M	2.9%	$2.56	—	COM	640268108
—	SELECTA BIOSCIENCES INC	2,558,474	$2.891M	2.8%	$1.20	—	COM	816212104
BHVN	BIOHAVEN LTD	179,085	$2.486M	2.4%	$14.12	0.0%	COM	G1110E107
RCKT	ROCKET PHARMACEUTICALS INC	125,176	$2.45M	2.4%	$15.60	+18.0%	COM	77313F106
—	MIRATI THERAPEUTICS INC	47,520	$2.153M	2.1%	$45.31	—	COM	60468T105
RGEN	REPLIGEN CORP	12,180	$2.062M	2.0%	$210.87	-14.0%	COM	759916109
—	ESSA PHARMA INC	811,555	$2.045M	2.0%	$2.52	—	COM NEW	29668H708
—	MEDAVAIL HOLDINGS INC	5,894,897	$1.767M	1.7%	$8.23	—	COM	58406B103
—	PRAXIS PRECISION MEDICINES I	630,584	$1.501M	1.5%	$2.38	—	COM	74006W108
—	MORPHOSYS AG	405,602	$1.452M	1.4%	$3.92	—	SPONSORED ADS	617760202
RPID	RAPID MICRO BIOSYSTEMS INC	699,664	$791K	0.8%	$15.69	-84.6%	CLASS A COM	75340L104
—	CURIS INC	827,397	$455K	0.4%	$0.60	—	COM NEW	231269200
NAUT	NAUTILUS BIOTECHNOLOGY INC	159,232	$287K	0.3%	$10.83	-82.2%	COM	63909J108
—	SCIENCE 37 HOLDINGS INC	384,397	$160K	0.2%	$2.01	—	COM	808644108
DNLI	DENALI THERAPEUTICS INC	4,479	$125K	0.1%	$29.75	0.0%	COM	24823R105